Form 4 Filing for Century Therapeutics, Inc.

This filing details a Form 4 filed by Murphy Martin Patrick, a director at Century Therapeutics, Inc. On December 9, 2025, Mr. Patrick was granted 88,000 stock options with a purchase price of $0.5920 per share. These options, exercisable immediately, will expire on December 9, 2035. The options vest in equal monthly installments over 36 months, contingent upon his continued service. This grant is part of his compensation in connection with his appointment as a director, issued under the Company's 2021 Equity Incentive Plan. The filing was signed on April 10, 2026, by Douglas Carr, acting as Attorney-in-Fact.